Bottom Line
Top 4 in Top 7 Things to Know About Brilinta
Brilinta inhibits a substance known as ADP (adenosine-5-diphosphate), which is important in blood clotting. It may be given in conjunction with aspirin to people who have had a heart attack or who have acute coronary syndrome (ACS) to lower their risk of having a stroke or other heart problems. Brilinta's most common side effects are bleeding, shortness of breath (dyspnea), dizziness, and nausea. Brilinta has been shown in studies to be more effective than clopidogrel (Plavix) in lowering the risk of CV death, MI, or stroke in the first year of treatment.
